Dicerna Pharma (DRNA) Reports Q1 Loss of $0.38/Share

Dicerna Pharma (NASDAQ: DRNA) reported Q1 EPS of ($0.38), versus ($0.30) reported last year. Revenue for the quarter came in at $3.1 million, versus $1.54 million reported last year.

For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery